Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

3D-bioprinting for joint regeneration

Li W., Wang Y., Cui Y., Wu Q., Ying P., Dai K.

Narrative Review on Cartilage Damage, Ligament Injury, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Bioeng Biotechnol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42027392
PMCID
PMC13099821
DOI
10.3389/fbioe.2026.1742269

Abstract (original English)

Joint injuries represent a significant clinical challenge with limited regenerative options. Three-dimensional (3D) bioprinting has emerged as a transformative technology, enabling the precise fabrication of patient-specific, anatomically matched, multilayered scaffolds that replicate the complex structure and gradient of natural joint tissues. This review comprehensively summarizes advances in bioprinting techniques, cell sources, and biomaterial formulations, emphasizing cell-laden bioinks composed of biomaterials and viable cells to create functional, bioactive constructs. Beyond basic fabrication, we evaluate the functional performance of bioprinted cartilage, bone, and ligaments, and we discuss strategies for engineering osteochondral interfaces and ligament-bone interfaces to support biomimetic mechanical properties and tissue integration. We further compare major printing modalities, including extrusion-based printing, inkjet, and laser-assisted bioprinting, and we discuss how modality-specific trade-offs in resolution, viscosity window, and cell stress influence construct fidelity and repair outcomes. In addition, we examine biofunctionalization strategies that incorporate growth factors, stem cells, and exosomes to enhance regenerative signaling and matrix remodeling. Notably, 3D bioprinting for joint regeneration is transitioning from bench to bedside, and we detail t

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research